Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Historical Acquisition Tree
Alternative names
Key: DCPrime BV (1) Acquired (4)
dcp-001 (2 trials)
ilixadencel (3 trials)
pembrolizumab (keytruda) (1 trial)
sunitinib (sutent) (1 trial)
tumor-pulsed dendritic cells (2 trials)
Key: DCPrime BV (0) Acquired (1)
allogeneic dendritic cells (1 trial)
Leukemia (Phase 2)
Leukemia, Myeloid (Phase 2)
Leukemia, Myeloid, Acute (Phase 2)
Trials (8 total)
Trial APIs (6 total)